In contrast, the B-ALL subtypes that were enriched for genes characteristic of other B cell differentiation stages, such as ETV6–RUNX1 and ZNF384 rearrangements, were the ones with favorable outcomes52–55 (Fig. 7a). The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.